Leukemia: all 5,475 studies
Page 31 of 55. Open to participants first (629), then studies with results posted, then the rest; newest registration first within each.
- Low-Dose Daunorubicin in Relapsed/Refractory Acute LeukemiaCompletedNCT02914977Phase 1
- Ruxolitinib Combined With Ibrutinib in Chronic Lymphocytic Leukemia PatientsStatus unknownNCT02912754Phase 1/2
- Thiopurine EnhAnced Maintenance TherapyCompletedNCT02912676Phase 1/2
- Safety Study of ALRN-6924 in Patients With Acute Myeloid Leukemia or Advanced Myelodysplastic SyndromeCompletedNCT02909972Phase 1
- Study of the Tocilizumab Optimization Timing for CART19 Associated Cytokine Release SyndromeCompletedNCT02906371Phase 1
- Volasertib Combined With Induction Chemotherapy in Acute Myeloid LeukemiaWithdrawnNCT02905994Phase 1
- Safety Study of BTK Inhibitor, DTRMWXHS-12, Used Singly or in Combination, in CLL and B-cell LymphomasCompletedNCT02900716Phase 1
- Invasives Aspergillosis in Acute Myeloid LeukemiaCompletedNCT02900430
- Transfusion in Adult Acute Myeloid LeukemiaCompletedNCT02899767
- Efficacy and Safety Study of Recombinant Human Arginase 1 in Patients With Relapsed or Refractory Acute Myeloid LeukemiaStatus unknownNCT02899286Phase 2
- Treatment of Non-high-risk Acute Promyelocytic Leukemia (APL) With Realgar-Indigo Naturalis Formula (RIF)Status unknownNCT02899169Phase 3
- Follow-up of the Persistence of the Complete Molecular Remission After Stopping Imatinib Chronic Myeloid LeukemiaCompletedNCT02896829
- Preparatory Work to Assess Adherence to Oral ChemotherapyCompletedNCT02895542
- Malaysia-Singapore Acute Lymphoblastic Leukemia 2010 StudyStatus unknownNCT02894645Phase 4
- PCAR-119 Bridge Immunotherapy Prior to Stem Cell Transplant in Treating Patients With CD19 Positive Leukemia and LymphomaStatus unknownNCT02892695Phase 1/2
- A Study Evaluating the Safety and Pharmacology of Atezolizumab Administered in Combination With Immunomodulatory Agents in Participants With Acute Myeloid Leukemia (AML)CompletedNCT02892318Phase 1
- An Observational Post Authorisation Study to Evaluate Safety and Efficacy in Patients Receiving Azacitidine in Daily Clinical Practice in the NetherlandsCompletedNCT02891551
- Sertraline and Cytosine Arabinoside in Adults With Relapsed and Refractory AMLCompletedNCT02891278Phase 1
- Dasatinib Holiday for Improved TolerabilityCompletedNCT02890784Phase 3
- Phase I Trial of Universal Donor NK Cell Therapy in Combination With ALT803CompletedNCT02890758Phase 1
- Dasatinib and Low Intensity Chemotherapy for Ph+ Acute Lymphoblastic LeukemiaCompletedNCT02888990Phase 2
- Tyrosine Kinase Inhibitors and Low Intensity Chemotherapy in Ph+ ALLStatus unknownNCT02888977
- Study to Evaluate Tolerability, Safety, Pharmacokinetics and Preliminary Efficacy of PF-114 for Oral Administration in Adults With Ph+ Chronic Myeloid Leukemia, Which is Resistant to the 2-nd Generation Bcr-Abl Inhibitors or Has T315I Mutation in the BCR-ABL GeneStatus unknownNCT02885766Phase 1/2
- Rituximab in Hairy Cell Leukemia: a Multicenter Retrospective StudyCompletedNCT02883946
- Vitro Study of Tigecycline to Treat Chronic Myeloid LeukemiaStatus unknownNCT02883036
- Ph 1 Study of ADI-PEG 20 Plus Low Dose Cytarabine in Older Patients With AMLTerminatedNCT02875093Phase 1
- MRD-directed Therapy for Low-risk and Intermediate-risk AML.CompletedNCT02870777Phase 2/3
- Regional Central Database Recording of Chronic Myeloid LeukemiaStatus unknownNCT02869256
- A Study to Evaluate Escalating Doses of ASP1235 (AGS62P1) Given as Monotherapy in Subjects With Acute Myeloid Leukemia (AML)TerminatedNCT02864290Phase 1
- Ibrutinib in Previously Untreated Binet Stage a Chronic Lymphocytic Leukemia with Risk of Disease ProgressionCompletedNCT02863718Phase 3
- Reflexology: An Intervention for Acute Myeloid Leukemia(AML) PatientsStatus unknownNCT02863302Not applicable
- Molecular Characterization of Acute Erythroid Leukemia (M6-AML) Using Targeted Next-generation SequencingCompletedNCT02861651
- Volasertib and Vincristine Sulfate Liposome in Treating Patients With Relapsed or Refractory Acute Lymphoblastic LeukemiaWithdrawnNCT02861040Phase 1
- Role of PTK-7 in Acute Myeloid LeukemiasCompletedNCT02860793Not applicable
- A Study of SKLB1028 in Subjects With Relapsed/Refractory Acute Myeloid LeukemiaStatus unknownNCT02859948Phase 1
- Neurocognitive and Psychosocial Outcomes in Survivors of Childhood Leukemia With Down SyndromeCompletedNCT02859389
- Shotgun Sequencing in Diagnosing Febrile Neutropenia in Patients With Acute Myeloid LeukemiaCompletedNCT02856204
- Study on Safety and Pharmacokinetics of Intravenous F901318 for Fungal Prophylaxis in AML PatientsWithdrawnNCT02856178Phase 1/2
- Study of Imatinib Discontinuation in Chronic Myeloid Leukemia With Deep Molecular ResponseCompletedNCT02852486Phase 2
- Study Evaluating the Efficacy and Safety of PCAR-019 in CD19 Positive Relapsed or Refractory Leukemia and LymphomaStatus unknownNCT02851589Phase 1/2
- Safety Study to Assess AFM11 in Patients With Relapsed or Refractory Adult B-precursor ALLTerminatedNCT02848911Phase 1
- A Safety Study of SGN-CD123A in Patients With Acute Myeloid LeukemiaTerminatedNCT02848248Phase 1
- Optimal Treatment Strategy Based on for Pediatric AMLStatus unknownNCT02848183Phase 2
- Identifying, Understanding, and Overcoming Barriers to the Use of Clinical Practice Guidelines in Pediatric OncologyCompletedNCT02847130
- Economic Analysis of Blood Product Transfusions According to the Treatment of Acute Myeloid Leukaemia in the ElderlyCompletedNCT02845232
- Transfusion Dependency at Diagnosis and Transfusion Intensity During Initial Chemotherapy Are Associated With Poorer Outcomes in Adult Acute Myeloid LeukaemiaCompletedNCT02844257
- Effect of Age on Treatment Decision-Making in Elderly Patients With Acute Myeloid LeukemiaCompletedNCT02844218
- Study of Predictive Immunological Parameters of Molecular Complete Remission in Patients With Chronic Myelogenous Leukemia in Chronic Phase and Treated With Tyrosine Kinase InhibitorCompletedNCT02842333Not applicable
- Targeting Leukemic Stem Cell Expressing the IL-1RAP Protein in Chronic Myelogenous Leukemia (CML)CompletedNCT02842320Not applicable
- A Study to Determine Final Geriatric Assessment in Haematology (GAH) Score as a Tool for Predicting Tolerance to Treatment in Elderly Patients (≥ 65 Years) With Haematologic NeoplasmsCompletedNCT02842229
- Higher Percentage of CD34+ CD38- Cells Detected by Multiparameter Flow Cytometry From Leukapheresis Products Predicts Unsustained Complete Remission in Acute Myeloid LeukemiaCompletedNCT02842112
- A Study of H3B-8800 (RVT-2001) in Participants With Lower Risk Myelodysplastic SyndromesTerminatedNCT02841540Phase 1
- A Study of Indoximod in Combination With (7+3) Chemotherapy in Patients With Newly Diagnosed Acute Myeloid LeukemiaCompletedNCT02835729Phase 1
- Microtransplantation in Older Patients With Acute Myeloid LeukemiaCompletedNCT02831192Phase 2
- Dose-Escalation Study of Ponatinib, a FLT3 Inhibitor, With and Without Combination of 5-Azacytidine, in Patients With FLT3-Mutated Acute Myeloid Leukemia (AML)WithdrawnNCT02829840Phase 1/2
- A Dose Finding Study of IDH305 With Standard of Care in IDH1 Mutant Acute Myeloid LeukemiaWithdrawnNCT02826642Phase 1
- Phase I/II, FIH, Dose Escalation Trial of TL-895 and Expansion of TL-895 Monotherapy and Combination Therapy With Navtemadlin in Tx-Naïve and R/R CLL/SLL SubjectsActive, not recruitingNCT02825836Phase 1/2
- Study of the Level of a Protein Which Could Predict the Development of a Fungal Infection in Patients With Acute LeukemiaCompletedNCT02823132
- Phase I Study of CD19-CAR-T2 Cells for Patients With Chemotherapy Resistant or Refractory CD19+ Acute LeukemiaStatus unknownNCT02822326Phase 1
- CAR-T Cell Immunotherapy in CD19 Positive Relapsed or Refractory Leukemia and LymphomaStatus unknownNCT02819583Phase 1/2
- Study of Pts With Philadelphia Chromosome-Pos ALL With Comb of Ibrutinib, Dasatinib, and PrednisoneWithdrawnNCT02815059Phase 1
- Bosutinib in Elderly Chronic Myeloid LeukemiaCompletedNCT02810990Phase 2
- Efficacy of CART-19 Cell Therapy in B Cell Acute Lymphoblastic LeukemiaStatus unknownNCT02810223Phase 1
- Interleukin-21 (IL-21)- Expanded Natural Killer Cells for Induction of Acute Myeloid LeukemiaStatus unknownNCT02809092Phase 1/2
- Study of UCART19 in Pediatric Patients With Relapsed/Refractory B Acute Lymphoblastic LeukemiaCompletedNCT02808442Phase 1
- Efficacy Study of Inecalcitol With Decitabine in Acute Myeloid Leukemia Patients Unfit for Standard ChemotherapyStatus unknownNCT02802267Phase 2
- Allogeneic CART-19 for Elderly Relapsed/Refractory CD19+ ALLStatus unknownNCT02799550Phase 1
- GVHD Prophylaxis With Post-transplantation Bendamustine in Refractory LeukemiaCompletedNCT02799147Phase 1/2
- Pharmacological Study of Intravenous OTS167 in Patients With Refractory or Relapsed Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Advanced Myelodysplastic Syndromes, Advanced Myeloproliferative Neoplastic Disorders, or Advanced Chronic Myelogenous LeukemiaTerminatedNCT02795520Phase 1/2
- Wee1 Kinase Inhibitor AZD1775 and Combination Chemotherapy in Treating Children, Adolescents and Young Adults With Relapsed or Refractory Acute Myeloid LeukemiaWithdrawnNCT02791919Phase 1
- FLYSYN in MRD Positive AMLCompletedNCT02789254Phase 1/2
- ACY-1215 in Combination With BCR Pathway Inhibitors in Relapsed CLLActive, not recruitingNCT02787369Phase 1
- Study of Busulfan and FLAG Conditioning Regimen for Allogeneic Peripheral Blood Stem Cell TransplantationStatus unknownNCT02784561Phase 4
- An Study of Patients With Ph- Chromosome-negative Relapsed or Refractory Acute Lymphoblastic Leukemia in the USCompletedNCT02783651
- Axitinib and Bosutinib in Treating Patients With Chronic, Accelerated, or Blastic Phase Chronic Myeloid LeukemiaTerminatedNCT02782403Phase 1
- A Safety Study of Human Cord Blood Derived, Culture Expanded Natural Killer Cell (PNK-007) Infusion With Subcutaneous Recombinant Human IL-2 (rhIL-2) in Adults With Relapsed and/or Refractory Acute Myeloid Leukemia (AML)TerminatedNCT02781467Phase 1
- Personalized Kinase Inhibitor Therapy Combined With Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia and Acute Lymphoblastic LeukemiaCompletedNCT02779283Phase 1
- Sequential Intensive Chemotherapy Followed by RIC for Refractory and Relapse ALLStatus unknownNCT02766868Phase 2
- StemRegenin-1 Expanded vs Unexpanded UCB for High Risk Heme MalignanciesWithdrawnNCT02765997Phase 2
- NK Cells as Consolidation Therapy of Acute Myeloid Leukemia in Children/AdolescentsCompletedNCT02763475Phase 2
- Haploidentical Hematopoietic Stem Cell Transplantation for Acute LeukemiasStatus unknownNCT02759822
- Trial of Ibrutinib Plus Venetoclax Plus Obinutuzumab in Patients With CLLCompletedNCT02758665Phase 2
- Treatment of Chronic Lymphocytic LeukemiaStatus unknownNCT02757586
- CIK-Cells in Relapsing Patients With Acute Leukemia or Myelodysplastic Syndromes After SCT.Status unknownNCT02752243Phase 1/2
- Peptide Vaccination in Combination With Azacitidine for Patients With MDS and AMLCompletedNCT02750995Phase 1
- Azacitidine in Haploidentical Donor Hematopoietic Cell TransplantationTerminatedNCT02750254Phase 1
- Study of IRX5183 in Relapsed and Refractory Acute Myeloid Leukemia and High Risk Myelodysplastic SyndromeTerminatedNCT02749708Phase 1
- Dose Escalation Study of UCART19 in Adult Patients With Relapsed / Refractory B-cell Acute Lymphoblastic LeukaemiaCompletedNCT02746952Phase 1
- D-ALBA Frontline Sequential Dasatinib and Blinatumomab in Adult Philadelphia Positive Acute Lymphoblastic LeukemiaStatus unknownNCT02744768Phase 2
- CAR-pNK Cell Immunotherapy in CD7 Positive Leukemia and LymphomaStatus unknownNCT02742727Phase 1/2
- Study Evaluating the Efficacy and Safety With CAR-T for Recurrent or Refractory Acute Non T Lymphocyte LeukemiaActive, not recruitingNCT02735291Not applicable
- A Study to Evaluate the Long-term Safety of Patients With Advanced Lymphoid Leukemia Who Have Been Previously Administered With UCART19Active, not recruitingNCT02735083Phase 1
- Long Term Effects of Tyrosine Kinase Inhibitor Therapy on Ovarian Reserve and Fertility in Patients With Chronic Myeloid Leukemia or Gastrointestinal Stromal TumorWithdrawnNCT02734823
- Metabolic Outcomes in Patients Receiving Tyrosine Kinase Inhibitor (TKI) Therapy With Dasatinib or NilotinibCompletedNCT02733445
- PH 1 Study to Evaluate Safety and Tolerability of XmAb14045 in Patients With CD123-expressing Hematologic MalignanciesCompletedNCT02730312Phase 1
- Sirolimus and Mycophenolate Mofetil in Preventing GVHD in Patients With Hematologic Malignancies Undergoing HSCTTerminatedNCT02728700Phase 1
- A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic LeukemiaCompletedNCT02723994Phase 2
- Midostaurin in Treating Older Patients With Mutated Acute Myeloid Leukemia Post-TransplantWithdrawnNCT02723435Phase 2
- A Study to Find a Safe Dose of Volasertib Given in Addition to Standard Salvage Chemotherapy in Children (Age 3 Months to Less Than 18 Years) With Acute Myeloid Leukaemia, in Whom Front-line Chemotherapy FailedWithdrawnNCT02722135Phase 1
- Refining a Biobehavioral Intervention to Enhance Recovery Following Hematopoietic Stem Cell TransplantationCompletedNCT02719821Not applicable